Shree Ganesh Remedies logo

540737 - Shree Ganesh Remedies Share Price

₹92.9 0.0  0.0%

Last Trade - 12/08/20

Micro Cap
Market Cap £8.53m
Enterprise Value £8.42m
Revenue £6.55m
Position in Universe 1635th / 3001
Unlock 540737 Revenue
Relative Strength (%)
1m -1.82%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -16.3%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
165 155.2 198.6 272.6 353.1 640.2 +31.2%
+17.6 -15.0 +141.3 +109.3 +13.1 +67.9
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 31 March 2020, Shree Ganesh Remedies Ltd revenues increased 81% to RS640.2M. Net income increased 68% to RS104.7M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was partially offset by Employee Benefit Expense increase of 89% to RS39.9M (expense). Dividend per share increased from RS1.25 to RS1.50.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


540737 Revenue Unlock 540737 Revenue

Net Income

540737 Net Income Unlock 540737 Revenue

Normalised EPS

540737 Normalised EPS Unlock 540737 Revenue

PE Ratio Range

540737 PE Ratio Range Unlock 540737 Revenue

Dividend Yield Range

540737 Dividend Yield Range Unlock 540737 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
540737 EPS Forecasts Unlock 540737 Revenue
Profile Summary

Shree Ganesh Remedies Limited is an India-based company. The Company is engaged in manufacturing and dispatching of drug intermediates and chemicals for pharmaceutical industry. The Company manufactures products relating to antipsychotic, antiseptic, deprotonation reactions, hyperlipidemia, alzheimers and anti-viral. The Company’s products portfolio include Di methyl amino propyl chloride HCl, Trityl chloride(TTCL), 4-Chloro 4 Fluoro Butyrophenone (CFBP), Methyl Cyclo Propane Carboxylate Acid/ Acid Chloride, 1-Bromo-4-Propylheptane (BPH), Sodium Bis (Trimethylsilyl) Amide in THF 1M/2M, Tyramine HCl /Base, Hexadienyl acetate(HDA), and Cyclo Propane Carboxylic Acid.

Last Annual March 31st, 2020
Last Interim March 31st, 2020
Incorporated April 27, 1995
Public Since October 13, 2017
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Pharmaceuticals
Exchange Bombay Stock Exchange
Shares in Issue 8,971,356
Free Float (0.0%)
Eligible for
540737 Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for 540737
Upcoming Events for 540737
Frequently Asked Questions for Shree Ganesh Remedies
What is the Shree Ganesh Remedies share price?

As of 12/08/20, shares in Shree Ganesh Remedies are trading at ₹92.9, giving the company a market capitalisation of £8.53m. This share price information is delayed by 15 minutes.

How has the Shree Ganesh Remedies share price performed this year?

Shares in Shree Ganesh Remedies are currently trading at ₹92.9 and the price has moved by 54.83% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Shree Ganesh Remedies price has moved by 50.8% over the past year.

What are the analyst and broker recommendations for Shree Ganesh Remedies?

There are no analysts currently covering Shree Ganesh Remedies.

When will Shree Ganesh Remedies next release its financial results?

Shree Ganesh Remedies is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-03-31
What is the Shree Ganesh Remedies dividend yield?

The Shree Ganesh Remedies dividend yield is 1.61% based on the trailing twelve month period.

Does Shree Ganesh Remedies pay a dividend?

Last year, Shree Ganesh Remedies paid a total dividend of 1.5, and it currently has a trailing dividend yield of 1.61%. Looking ahead, Shree Ganesh Remedies has not announced an ex-dividend date yet.

When does Shree Ganesh Remedies next pay dividends?

Shree Ganesh Remedies has yet to annouce their ex-dividend date. The historic dividend yield on Shree Ganesh Remedies shares is currently 1.61%.

How do I buy Shree Ganesh Remedies shares?

To buy shares in Shree Ganesh Remedies you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Shree Ganesh Remedies?

Shares in Shree Ganesh Remedies are currently trading at ₹92.9, giving the company a market capitalisation of £8.53m.

Where are Shree Ganesh Remedies shares listed? Where are Shree Ganesh Remedies shares listed?

Here are the trading details for Shree Ganesh Remedies:

Country of listing: India
Exchange: BSE
Ticker Symbol: 540737
What kind of share is Shree Ganesh Remedies?

Based on an overall assessment of its quality, value and momentum, Shree Ganesh Remedies is currently classified as a Style Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Shree Ganesh Remedies share price forecast 2020?

We were not able to load any forecast data for Shree Ganesh Remedies.

How can I tell whether the Shree Ganesh Remedies share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Shree Ganesh Remedies. Over the past six months, the relative strength of its shares against the market has been 37.27%. At the current price of ₹92.9, shares in Shree Ganesh Remedies are trading at 27.48% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Shree Ganesh Remedies PE Ratio?

The Shree Ganesh Remedies PE ratio based on its reported earnings over the past 12 months is 7.96. The shares are currently trading at ₹92.9.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Shree Ganesh Remedies?

We were unable to find the directors for Shree Ganesh Remedies.

Who are the major shareholders of Shree Ganesh Remedies?

Here are the top five shareholders of Shree Ganesh Remedies based on the size of their shareholding:

Kothiya (Manubhai Jivabhai) Individual Investor
Percentage owned: 11.4% (1.02m shares)
Kothia (Hasmukbhai Manubhai) Individual Investor
Percentage owned: 8.46% (759k shares)
Kothia (Chandulal Manubhai) Individual Investor
Percentage owned: 8.06% (723k shares)
Kothia (Subhashbhai Babubhai) Individual Investor
Percentage owned: 5.74% (515k shares)
Kothia (Hanshaben Chandubhai) Individual Investor
Percentage owned: 5.32% (477k shares)
Similar to 540737
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.